Industry Resources | December 27, 2016
United States v. Insys Executives Michael L. Babich, Alec Burlakoff, Michael J. Gurry, Richard M. Simon, Sunrise Lee & Joseph A. Rowan
On December 6, 2016, U.S. Federal prosecutors filed this indictment against key ex-employees of Arizona drug company Insys Therapeutics. The indictment alleges that the defendants conspired to give bribes and kickbacks to practitioners to prescribe a powerful, fentanyl-based narcotic for cancer treatment to consumers who weren’t diagnosed with cancer. Additionally, the former executives are charged with conspiring to defraud insurers that hesitated to approve payment for patients who didn’t have cancer . . .